Lumicell Drug Patent Portfolio
Lumicell owns 1 orange book drug protected by 6 US patents Given below is the list of Lumicell's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9763577 | Imaging agent for detection of diseased cells | 14 Sep, 2034 | Active |
| US10285759 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
| US9032965 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
| US9532835 | Methods and system for image guided cell ablation with microscopic resolution | 08 Dec, 2031 | Active |
| US9155471 | Methods and systems for spatially identifying abnormal cells | 12 Oct, 2031 | Active |
| US11592396 | Methods and systems for spatially identifying abnormal cells | 01 Sep, 2030 | Active |
Latest Legal Activities on Lumicell's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lumicell.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Information Disclosure Statement (IDS) Filed | 26 Aug, 2025 | US9763577 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US9763577 |
| transaction for FDA Determination of Regulatory Review Period | 01 Aug, 2025 | US9763577 |
| Second letter to regulating agency to determine regulatory review period | 27 May, 2025 | US9763577 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 19 Mar, 2025 | US9763577 |
| Letter from FDA or Dept of Agriculture re PTE application | 17 Mar, 2025 | US9763577 |
| Initial letter Re: PTE Application to regulating agency | 13 Sep, 2024 | US9763577 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 03 Jul, 2024 | US9532835 |
|
Email Notification
Critical
| 21 Jun, 2024 | US9763577 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 21 Jun, 2024 | US9763577 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Jun, 2024 | US9763577 |
| Electronic Review | 10 May, 2023 | US11592396 |
| Post Issue Communication - Certificate of Correction | 21 Apr, 2023 | US11592396 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 13 Apr, 2023 | US9155471 |
| Patent Issue Date Used in PTA Calculation | 28 Feb, 2023 | US11592396 |
Lumicell's Family Patents
Lumicell Drug List
Given below is the complete list of Lumicell's drugs and the patents protecting them.
1. Lumisight
Lumisight is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9763577 | Imaging agent for detection of diseased cells |
14 Sep, 2034
(8 years from now)
| Active |
| US10285759 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(5 years from now)
| Active |
| US9032965 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(5 years from now)
| Active |
| US9532835 | Methods and system for image guided cell ablation with microscopic resolution |
08 Dec, 2031
(5 years from now)
| Active |
| US9155471 | Methods and systems for spatially identifying abnormal cells |
12 Oct, 2031
(5 years from now)
| Active |
| US11592396 | Methods and systems for spatially identifying abnormal cells |
01 Sep, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lumisight's drug page